SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates PGTI, X, THRX, AYX


NEW YORK, Jan. 23, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Halper Sadeh LLC (PRNewsfoto/Halper Sadeh LLP)

PGT Innovations, Inc. (NYSE: PGTI)'s sale to MITER Brands for $42.00 per share in cash. If you are a PGT shareholder, click here to learn more about your rights and options.

United States Steel Corporation (NYSE: X)'s sale to Nippon Steel Corporation for $55.00 per share. If you are a U. S. Steel shareholder, click here to learn more about your rights and options.  

Theseus Pharmaceuticals, Inc. (NASDAQ: THRX)'s sale to Concentra Biosciences, LLC for between $3.90 and $4.05 in cash. If you are a Theseus shareholder, click here to learn more about your rights and options.

Alteryx, Inc. (NYSE: AYX)'s sale to Clearlake Capital Group, L.P. and Insight Partners for $48.25 per share in cash for each share of Alteryx Class A or Class B common stock. If you are an Alteryx shareholder, click here to learn more about your rights and options. 

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-notice-halper-sadeh-llc-investigates-pgti-x-thrx-ayx-302042342.html

SOURCE Halper Sadeh LLP

Werbung

Theseus Pharmaceuticals Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Theseus Pharmaceuticals nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"

Keine Analysen gefunden.

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.